Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Auna SA stock logo
AUNA
Auna
$6.68
-2.1%
$6.97
$6.50
$9.38
$492.19M3.261,999 shs18,603 shs
Enhabit, Inc. stock logo
EHAB
Enhabit
$10.22
-0.4%
$8.70
$6.85
$10.79
$517.31M1.61455,843 shs209,368 shs
Talkspace, Inc. stock logo
TALK
Talkspace
$2.82
+2.2%
$2.87
$1.60
$4.36
$471.83M1.131.87 million shs1.18 million shs
Exagen Inc. stock logo
XGN
Exagen
$6.60
+9.5%
$5.07
$1.71
$7.20
$140.58M1.5114,984 shs600,762 shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Auna SA stock logo
AUNA
Auna
-1.77%-4.03%-3.89%-17.49%-24.49%
Enhabit, Inc. stock logo
EHAB
Enhabit
-0.48%-4.03%+35.85%+25.58%+8.45%
Talkspace, Inc. stock logo
TALK
Talkspace
+2.17%-5.37%-0.35%-6.31%+2.17%
Exagen Inc. stock logo
XGN
Exagen
+9.45%+9.82%+15.38%+84.36%+252.94%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Auna SA stock logo
AUNA
Auna
3.3784 of 5 stars
3.22.00.00.02.40.03.1
Enhabit, Inc. stock logo
EHAB
Enhabit
2.0719 of 5 stars
1.05.00.00.03.60.82.5
Talkspace, Inc. stock logo
TALK
Talkspace
3.7247 of 5 stars
3.53.00.00.02.54.21.9
Exagen Inc. stock logo
XGN
Exagen
4.201 of 5 stars
3.53.00.04.52.32.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Auna SA stock logo
AUNA
Auna
2.33
Hold$10.7060.30% Upside
Enhabit, Inc. stock logo
EHAB
Enhabit
2.00
Hold$8.50-16.80% Downside
Talkspace, Inc. stock logo
TALK
Talkspace
3.00
Buy$4.5059.57% Upside
Exagen Inc. stock logo
XGN
Exagen
3.00
Buy$7.5013.64% Upside

Current Analyst Ratings Breakdown

Latest XGN, EHAB, AUNA, and TALK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/22/2025
Auna SA stock logo
AUNA
Auna
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/22/2025
Auna SA stock logo
AUNA
Auna
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Hold$7.90
5/15/2025
Exagen Inc. stock logo
XGN
Exagen
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
5/15/2025
Exagen Inc. stock logo
XGN
Exagen
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$8.00 ➝ $7.00
5/13/2025
Exagen Inc. stock logo
XGN
Exagen
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$7.00 ➝ $8.00
5/7/2025
Exagen Inc. stock logo
XGN
Exagen
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/6/2025
Talkspace, Inc. stock logo
TALK
Talkspace
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
4/3/2025
Talkspace, Inc. stock logo
TALK
Talkspace
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$5.00
3/12/2025
Exagen Inc. stock logo
XGN
Exagen
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
3/6/2025
Enhabit, Inc. stock logo
EHAB
Enhabit
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Auna SA stock logo
AUNA
Auna
$4.35B0.11N/AN/AN/A
Enhabit, Inc. stock logo
EHAB
Enhabit
$1.03B0.50$3.14 per share3.25$13.90 per share0.73
Talkspace, Inc. stock logo
TALK
Talkspace
$194.36M2.43N/AN/A$0.71 per share3.97
Exagen Inc. stock logo
XGN
Exagen
$56.72M2.48N/AN/A$1.33 per share4.96
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Auna SA stock logo
AUNA
Auna
-$67.90M$0.5811.518.45N/AN/AN/AN/AN/A
Enhabit, Inc. stock logo
EHAB
Enhabit
-$80.50M-$2.77N/A35.23N/A-11.24%1.67%0.80%8/5/2025 (Estimated)
Talkspace, Inc. stock logo
TALK
Talkspace
-$19.18M$0.02282.2814.84N/A0.61%0.98%0.84%8/5/2025 (Estimated)
Exagen Inc. stock logo
XGN
Exagen
-$23.69M-$0.84N/AN/AN/A-30.36%-92.58%-33.74%8/4/2025 (Estimated)

Latest XGN, EHAB, AUNA, and TALK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/20/2025Q1 2025
Auna SA stock logo
AUNA
Auna
$0.16$0.19+$0.03$0.13$1.12 billion$281.43 million
5/12/2025Q1 2025
Exagen Inc. stock logo
XGN
Exagen
-$0.20-$0.20N/A-$0.20$14.55 million$15.50 million
5/7/2025Q1 2025
Enhabit, Inc. stock logo
EHAB
Enhabit
$0.07$0.10+$0.03$0.35$266.11 million$259.90 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Auna SA stock logo
AUNA
Auna
N/AN/AN/AN/AN/A
Enhabit, Inc. stock logo
EHAB
Enhabit
N/AN/AN/AN/AN/A
Talkspace, Inc. stock logo
TALK
Talkspace
N/AN/AN/AN/AN/A
Exagen Inc. stock logo
XGN
Exagen
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Auna SA stock logo
AUNA
Auna
1.87
0.88
0.81
Enhabit, Inc. stock logo
EHAB
Enhabit
0.85
1.46
1.46
Talkspace, Inc. stock logo
TALK
Talkspace
N/A
6.90
6.90
Exagen Inc. stock logo
XGN
Exagen
1.54
4.05
4.05

Institutional Ownership

CompanyInstitutional Ownership
Auna SA stock logo
AUNA
Auna
N/A
Enhabit, Inc. stock logo
EHAB
Enhabit
N/A
Talkspace, Inc. stock logo
TALK
Talkspace
57.37%
Exagen Inc. stock logo
XGN
Exagen
75.25%

Insider Ownership

CompanyInsider Ownership
Auna SA stock logo
AUNA
Auna
N/A
Enhabit, Inc. stock logo
EHAB
Enhabit
1.90%
Talkspace, Inc. stock logo
TALK
Talkspace
23.50%
Exagen Inc. stock logo
XGN
Exagen
12.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Auna SA stock logo
AUNA
Auna
14,95874.01 millionN/AN/A
Enhabit, Inc. stock logo
EHAB
Enhabit
10,90050.64 million49.33 millionOptionable
Talkspace, Inc. stock logo
TALK
Talkspace
500167.32 million132.27 millionOptionable
Exagen Inc. stock logo
XGN
Exagen
22021.30 million13.03 millionOptionable

Recent News About These Companies

FY2025 EPS Estimates for Exagen Reduced by Cantor Fitzgerald
Exagen (NASDAQ:XGN) Price Target Raised to $8.00

New MarketBeat Followers Over Time

Media Sentiment Over Time

Auna stock logo

Auna NYSE:AUNA

$6.68 -0.15 (-2.13%)
Closing price 05/23/2025 03:58 PM Eastern
Extended Trading
$6.68 0.00 (0.00%)
As of 05/23/2025 04:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.

Enhabit stock logo

Enhabit NYSE:EHAB

$10.22 -0.04 (-0.43%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$10.22 0.00 (-0.01%)
As of 05/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

Talkspace stock logo

Talkspace NASDAQ:TALK

$2.82 +0.06 (+2.17%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$2.82 0.00 (0.00%)
As of 05/23/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Talkspace, Inc. operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists. The company offers Talkspace Employee Assistance Program (EAP) and Talkspace Behavioral Health plan (BH) that provides online therapy to members through BH and EAP offerings; and Talkspace for Business for members to access its platform services on a benefit plan paid by the enterprise. It serves its platform through third-party platforms or marketplace, such as Apple App Store and Google Play App Store. Talkspace, Inc. was founded in 2012 and is headquartered in New York, New York.

Exagen stock logo

Exagen NASDAQ:XGN

$6.60 +0.57 (+9.45%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$6.73 +0.13 (+1.97%)
As of 05/23/2025 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Exagen Inc. develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP test, which identifies RA patients with severe disease. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.